GLS and neoplasm: The hypermethylation of the BCAT1 promoter inhibits the BCAT1 gene, and the decrease in the expression of BCAT1 reduces the supply of glutamate, increases the dependence on glutaminase, and reduces tumor proliferation and invasion (Yi et al., 2021).